Drug Profile
Norovirus vaccine intranasal - National Resilience
Alternative Names: GelVac® Norovirus; GelVac® Norovirus vaccineLatest Information Update: 18 Jun 2021
Price :
$50
*
At a glance
- Originator Nanotherapeutics
- Developer National Resilience
- Class Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Norovirus infections
Most Recent Events
- 28 Aug 2018 No recent reports of development identified for preclinical development in Norovirus-infections(Prevention) in USA (Inhalation, Powder)
- 02 Oct 2017 Nanotherapeutics is now called Ology Bioservices